Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
In conclusion, intranasal low-dose naltrexone counteracted morphine and oxycodone induced gastrointestinal and CNS side effects without impairing opioid analgesia. It is a candidate to be a valid clinical strategy deserving deep analysis.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Addiction | Constipation | Drugs & Pharmacology | Gastroenterology | Metoclopramide | Morphine | Oxycodone | OxyContin | Pain | Study